Sibling rivalry in the e2f family

Sibling rivalry in the e2f family

Play all audios:

Loading...

ABSTRACT The E2F transcription factor family determines whether or not a cell will divide by controlling the expression of key cell-cycle regulators. The individual E2Fs can be divided into


distinct subgroups that act in direct opposition to one another to promote either cellular proliferation or cell-cycle exit and terminal differentiation. What is the underlying molecular


basis of this 'push-me–pull-you' regulation, and what are its biological consequences? Access through your institution Buy or subscribe This is a preview of subscription content,


access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12 print issues and online access $209.00 per year only $17.42 per issue Learn


more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS


OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support SIMILAR CONTENT BEING VIEWED BY OTHERS SYSTEMATIC IDENTIFICATION OF CELL-FATE


REGULATORY PROGRAMS USING A SINGLE-CELL ATLAS OF MOUSE DEVELOPMENT Article 11 July 2022 THE ROLE(S) OF NF-Y IN DEVELOPMENT AND DIFFERENTIATION Article Open access 26 September 2024


TRANSCRIPTION FACTOR NETWORKS IN CELLULAR QUIESCENCE Article 09 January 2025 REFERENCES * Sherr, C. J. & Roberts, J. M. CDK inhibitors: positive and negative regulators of G1-phase


progression. _Genes Dev._ 13, 1501–1512 (1999). Article  CAS  PubMed  Google Scholar  * Nevins, J. R. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. _Science_


258, 424–429 (1992). Article  CAS  PubMed  Google Scholar  * Dyson, N. The regulation of E2F by pRB-family proteins. _Genes Dev._ 12, 2245–2262 (1998). Article  CAS  PubMed  Google Scholar 


* La Thangue, N. B. & Rigby, P. W. An adenovirus E1A-like transcription factor is regulated during the differentiation of murine embryonal carcinoma stem cells. _Cell_ 49, 507–513


(1987). Article  CAS  PubMed  Google Scholar  * Bandara, L. R. & La Thangue, N. B. Adenovirus E1a prevents the retinoblastoma gene product from complexing with a cellular transcription


factor. _Nature_ 351, 494–497 (1991). Article  CAS  PubMed  Google Scholar  * Girling, R. et al. A new component of the transcription factor DRTF1/E2F. _Nature_ 362, 83–87 (1993). Article 


CAS  PubMed  Google Scholar  * Weinberg, R. A. The retinoblastoma gene and gene product. _Cancer Surv._ 12, 43–57 (1992). CAS  PubMed  Google Scholar  * DeGregori, J., Leone, G., Ohtani, K.,


Miron, A. & Nevins, J. R. E2F-1 accumulation bypasses a G1 arrest resulting from the inhibition of G1 cyclin-dependent kinase activity. _Genes Dev._ 9, 2873–2887 (1995). Article  CAS 


PubMed  Google Scholar  * Schwarz, J. K. et al. Expression of the E2F1 transcription factor overcomes type-β transforming growth factor-mediated growth suppression. _Proc. Natl Acad. Sci.


USA_ 92, 483–487 (1995). Article  CAS  PubMed  PubMed Central  Google Scholar  * Mann, D. J. & Jones, N. C. E2F-1 but not E2F-4 can overcome p16-induced G1 cell-cycle arrest. _Curr.


Biol._ 6, 474–483 (1996). Article  CAS  PubMed  Google Scholar  * Bartek, J., Bartkova, J. & Lukas, J. The retinoblastoma protein pathway and the restriction point. _Curr. Opin. Cell


Biol._ 8, 805–814 (1996). Article  CAS  PubMed  Google Scholar  * Sherr, C. J. Cancer cell cycles. _Science_ 274, 1672–1677 (1996). Article  CAS  PubMed  Google Scholar  * Mulligan, G. &


Jacks, T. The retinoblastoma gene family: cousins with overlapping interests. _Trends Genet._ 14, 223–229 (1998). Article  CAS  PubMed  Google Scholar  * Hu, N. et al. Heterozygous Rb-1


delta 20/+ mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance. _Oncogene_ 9, 1021–1027 (1994). CAS  PubMed  Google Scholar  * Williams, B. O.,


Morgenbesser, S. D., DePinho, R. A. & Jacks, T. Tumorigenic and developmental effects of combined germ-line mutations in _Rb_ and _p53_. _Cold Spring Harb. Symp. Quant. Biol._ 59,


449–457 (1994). Article  CAS  PubMed  Google Scholar  * Clarke, A. R. et al. Requirement for a functional _Rb-1_ gene in murine development. _Nature_ 359, 328–330 (1992). Article  CAS 


PubMed  Google Scholar  * Jacks, T. et al. Effects of an _Rb_ mutation in the mouse. _Nature_ 359, 295–300 (1992). Article  CAS  PubMed  Google Scholar  * Lee, E. Y. et al. Mice deficient


for Rb are nonviable and show defects in neurogenesis and haematopoiesis. _Nature_ 359, 288–294 (1992). Article  CAS  PubMed  Google Scholar  * Helin, K. et al. A cDNA encoding a pRB-binding


protein with properties of the transcription factor E2F. _Cell_ 70, 337–350 (1992). Article  CAS  PubMed  Google Scholar  * Flemington, E. K., Speck, S. H. & Kaelin, W. G. Jr.


E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product. _Proc. Natl Acad. Sci. USA_ 90, 6914–6918 (1993). Article  CAS  PubMed 


PubMed Central  Google Scholar  * Helin, K., Harlow, E. & Fattaey, A. Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. _Mol. Cell. Biol._ 13,


6501–6508 (1993). Article  CAS  PubMed  PubMed Central  Google Scholar  * Zhang, H. S. & Dean, D. C. Rb-mediated chromatin structure regulation and transcriptional repression. _Oncogene_


20, 3134–3138 (2001). Article  CAS  PubMed  Google Scholar  * Brehm, A. et al. Retinoblastoma protein recruits histone deacetylase to repress transcription. _Nature_ 391, 597–601 (1998).


Article  CAS  PubMed  Google Scholar  * Luo, R. X., Postigo, A. A. & Dean, D. C. Rb interacts with histone deacetylase to repress transcription. _Cell_ 92, 463–473 (1998). Article  CAS 


PubMed  Google Scholar  * Chen, T. T. & Wang, J. Y. Establishment of irreversible growth arrest in myogenic differentiation requires the RB LXCXE-binding function. _Mol. Cell. Biol._ 20,


5571–5580 (2000). Article  CAS  PubMed  PubMed Central  Google Scholar  * Dahiya, A., Gavin, M. R., Luo, R. X. & Dean, D. C. Role of the LXCXE binding site in Rb function. _Mol. Cell.


Biol._ 20, 6799–6805 (2000). Article  CAS  PubMed  PubMed Central  Google Scholar  * Strobeck, M. W. et al. BRG-1 is required for RB-mediated cell cycle arrest. _Proc. Natl Acad. Sci. USA_


97, 7748–7753 (2000). Article  CAS  PubMed  PubMed Central  Google Scholar  * Zhang, H. S. et al. Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing


HDAC–Rb–hSWI/SNF and Rb–hSWI/SNF. _Cell_ 101, 79–89 (2000). Article  CAS  PubMed  Google Scholar  * Nielsen, S. J. et al. Rb targets histone H3 methylation and HP1 to promoters. _Nature_


412, 561–565 (2001).THIS STUDY SHOWS THAT PRB ASSOCIATES WITH BOTH SUV39H1 AND HP1 THROUGH ITS POCKET DOMAIN. SUV39H1 COOPERATES WITH PRB IN THE TRANSCRIPTIONAL REPRESSION OF THE


E2F-RESPONSIVE _CYCLIN E_ PROMOTER. MOREOVER, _IN VIVO_ CHIP ASSAYS SHOW THAT HP1 IS RECRUITED TO THE _CYCLIN E_ PROMOTER IN A PRB-DEPENDENT MANNER. Article  CAS  PubMed  Google Scholar  *


Vandel, L. et al. Transcriptional repression by the retinoblastoma protein through the recruitment of a histone methyltransferase. _Mol. Cell. Biol._ 21, 6484–6494 (2001). Article  CAS 


PubMed  PubMed Central  Google Scholar  * Harbour, J. W. & Dean, D. C. The Rb/E2F pathway: expanding roles and emerging paradigms. _Genes Dev._ 14, 2393–2409 (2000). Article  CAS  PubMed


  Google Scholar  * Bannister, A. J. et al. Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromodomain. _Nature_ 410, 120–124 (2001). Article  CAS  PubMed  Google


Scholar  * Lachner, M., O'Carroll, D., Rea, S., Mechtler, K. & Jenuwein, T. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. _Nature_ 410, 116–120 (2001).


Article  CAS  PubMed  Google Scholar  * Helin, K. Regulation of cell proliferation by the E2F transcription factors. _Curr. Opin. Genet. Dev._ 8, 28–35 (1998). Article  CAS  PubMed  Google


Scholar  * Bandara, L. R., Buck, V. M., Zamanian, M., Johnston, L. H. & La Thangue, N. B. Functional synergy between DP-1 and E2F-1 in the cell cycle-regulating transcription factor


DRTF1/E2F. _EMBO J._ 12, 4317–4324 (1993). Article  CAS  PubMed  PubMed Central  Google Scholar  * Helin, K. et al. Heterodimerization of the transcription factors E2F-1 and DP-1 leads to


cooperative _trans_-activation. _Genes Dev._ 7, 1850–1861 (1993). Article  CAS  PubMed  Google Scholar  * Krek, W., Livingston, D. M. & Shirodkar, S. Binding to DNA and the


retinoblastoma gene product promoted by complex formation of different E2F family members. _Science_ 262, 1557–1560 (1993). Article  CAS  PubMed  Google Scholar  * Wu, C. L., Zukerberg, L.


R., Ngwu, C., Harlow, E. & Lees, J. A. _In vivo_ association of E2F and DP family proteins. _Mol. Cell. Biol._ 15, 2536–2546 (1995). Article  CAS  PubMed  PubMed Central  Google Scholar


  * Trimarchi, J. M. et al. E2F-6, a member of the E2F family that can behave as a transcriptional repressor. _Proc. Natl Acad. Sci. USA_ 95, 2850–2855 (1998). Article  CAS  PubMed  PubMed


Central  Google Scholar  * Takahashi, Y., Rayman, J. B. & Dynlacht, B. D. Analysis of promoter binding by the E2F and pRB families _in vivo_: distinct E2F proteins mediate activation and


repression. _Genes Dev._ 14, 804–816 (2000).THIS STUDY USES _IN VIVO_ CHIP ASSAYS TO EXAMINE THE CELL-CYCLE-DEPENDENT ASSOCIATION OF INDIVIDUAL E2F AND POCKET PROTEINS WITH SEVERAL


E2F-RESPONSIVE PROMOTERS. IN G0/G1, THESE PROMOTERS ARE PRIMARILY OCCUPIED BY E2F4, P107 AND P130. AS CELLS ENTER LATE G1, THERE IS A SIGNIFICANT REDUCTION IN THE BINDING OF THESE PROTEINS


AND E2F1, E2F2 AND E2F3 NOW ASSOCIATE. THERE WAS NO DETECTABLE DIFFERENCE IN THE SPECTRUM OF E2FS AT INDIVIDUAL RESPONSIVE GENES, WHICH INDICATES THAT THEY COULD ALL BE REGULATED SIMILARLY.


CAS  PubMed  PubMed Central  Google Scholar  * Wells, J., Boyd, K. E., Fry, C. J., Bartley, S. M. & Farnham, P. J. Target gene specificity of E2F and pocket protein family members in


living cells. _Mol. Cell. Biol._ 20, 5797–5807 (2000). Article  CAS  PubMed  PubMed Central  Google Scholar  * Kaelin, W. G. Jr et al. Expression cloning of a cDNA encoding a


retinoblastoma-binding protein with E2F-like properties. _Cell_ 70, 351–364 (1992). Article  CAS  PubMed  Google Scholar  * Shan, B. et al. Molecular cloning of cellular genes encoding


retinoblastoma-associated proteins: identification of a gene with properties of the transcription factor E2F. _Mol. Cell. Biol._ 12, 5620–5631 (1992). Article  CAS  PubMed  PubMed Central 


Google Scholar  * Ivey-Hoyle, M. et al. Cloning and characterization of E2F-2, a novel protein with the biochemical properties of transcription factor E2F. _Mol. Cell. Biol._ 13, 7802–7812


(1993). Article  CAS  PubMed  PubMed Central  Google Scholar  * Lees, J. A. et al. The retinoblastoma protein binds to a family of E2F transcription factors. _Mol. Cell. Biol._ 13, 7813–7825


(1993). Article  CAS  PubMed  PubMed Central  Google Scholar  * Leone, G. et al. Identification of a novel E2F3 product suggests a mechanism for determining specificity of repression by Rb


proteins. _Mol. Cell. Biol._ 20, 3626–3632 (2000). Article  CAS  PubMed  PubMed Central  Google Scholar  * Johnson, D. G., Schwarz, J. K., Cress, W. D. & Nevins, J. R. Expression of


transcription factor E2F1 induces quiescent cells to enter S phase. _Nature_ 365, 349–352 (1993). Article  CAS  PubMed  Google Scholar  * Qin, X. Q., Livingston, D. M., Kaelin, W. G. Jr


& Adams, P. D. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. _Proc. Natl Acad. Sci. USA_ 91, 10918–10922 (1994). Article  CAS 


PubMed  PubMed Central  Google Scholar  * Lukas, J., Petersen, B. O., Holm, K., Bartek, J. & Helin, K. Deregulated expression of E2F family members induces S-phase entry and overcomes


p16INK4A-mediated growth suppression. _Mol. Cell. Biol._ 16, 1047–1057 (1996). Article  CAS  PubMed  PubMed Central  Google Scholar  * Johnson, D. G., Cress, W. D., Jakoi, L. & Nevins,


J. R. Oncogenic capacity of the _E2F1_ gene. _Proc. Natl Acad. Sci. USA_ 91, 12823–12827 (1994). Article  CAS  PubMed  PubMed Central  Google Scholar  * Shan, B. & Lee, W. H. Deregulated


expression of E2F-1 induces S-phase entry and leads to apoptosis. _Mol. Cell. Biol._ 14, 8166–8173 (1994). Article  CAS  PubMed  PubMed Central  Google Scholar  * Singh, P., Wong, S. H.


& Hong, W. Overexpression of E2F-1 in rat embryo fibroblasts leads to neoplastic transformation. _EMBO J._ 13, 3329–3338 (1994). Article  CAS  PubMed  PubMed Central  Google Scholar  *


Xu, G., Livingston, D. M. & Krek, W. Multiple members of the E2F transcription factor family are the products of oncogenes. _Proc. Natl Acad. Sci. USA_ 92, 1357–1361 (1995). Article  CAS


  PubMed  PubMed Central  Google Scholar  * Leone, G. et al. E2F3 activity is regulated during the cell cycle and is required for the induction of S phase. _Genes Dev._ 12, 2120–2130 (1998).


Article  CAS  PubMed  PubMed Central  Google Scholar  * Humbert, P. O. et al. _E2f3_ is critical for normal cellular proliferation. _Genes Dev._ 14, 690–703 (2000).THIS STUDY SHOWS THAT


E2F3 ACTS IN A DOSE-DEPENDENT MANNER TO MEDIATE THE MITOGEN-INDUCED ACTIVATION OF ALMOST ALL KNOWN E2F-RESPONSIVE GENES. AS A RESULT, E2F3 CONTROLS THE RATE OF PROLIFERATION OF BOTH PRIMARY


AND TRANSFORMED MEFS. CAS  PubMed  PubMed Central  Google Scholar  * Wu, L. et al. The E2F1–3 transcription factors are essential for cellular proliferation. _Nature_ 414, 457–462


(2001).USING THE CONDITIONAL MUTANT _E2F_ ALLELES, THE AUTHORS SHOW THAT THE COMBINED LOSS OF E2F1, E2F2 AND E2F3 COMPLETELY BLOCKS THE PROLIFERATION OF MEFS. THIS IS ACCOMPANIED BY AN


INCREASE IN THE LEVELS OF THE CDK INHIBITOR P21. Article  CAS  PubMed  Google Scholar  * Wu, X. & Levine, A. J. p53 and E2F-1 cooperate to mediate apoptosis. _Proc. Natl Acad. Sci. USA_


91, 3602–3606 (1994). Article  CAS  PubMed  PubMed Central  Google Scholar  * Hiebert, S. W. et al. E2F-1:DP-1 induces p53 and overrides survival factors to trigger apoptosis. _Mol. Cell.


Biol._ 15, 6864–6874 (1995). Article  CAS  PubMed  PubMed Central  Google Scholar  * Hsieh, J. K., Fredersdorf, S., Kouzarides, T., Martin, K. & Lu, X. E2F1-induced apoptosis requires


DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction. _Genes Dev._ 11, 1840–1852 (1997). Article  CAS  PubMed  Google Scholar  *


Phillips, A. C., Bates, S., Ryan, K. M., Helin, K. & Vousden, K. H. Induction of DNA synthesis and apoptosis are separable functions of E2F-1. _Genes Dev._ 11, 1853–1863 (1997). Article


  CAS  PubMed  Google Scholar  * Phillips, A. C., Ernst, M. K., Bates, S., Rice, N. R. & Vousden, K. H. E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways. _Mol.


Cell_ 4, 771–781 (1999). Article  CAS  PubMed  Google Scholar  * DeGregori, J., Leone, G., Miron, A., Jakoi, L. & Nevins, J. R. Distinct roles for E2F proteins in cell growth control and


apoptosis. _Proc. Natl Acad. Sci. USA_ 94, 7245–7250 (1997). Article  CAS  PubMed  PubMed Central  Google Scholar  * Bates, S. et al. p14ARF links the tumour suppressors RB and p53.


_Nature_ 395, 124–125 (1998). Article  CAS  PubMed  Google Scholar  * Tolbert, D., Lu, X., Yin, C., Tantama, M. & Van Dyke, T. p19ARF is dispensable for oncogenic stress-induced


p53-mediated apoptosis and tumor suppression _in vivo_. _Mol. Cell. Biol._ 22, 370–377 (2002). Article  CAS  PubMed  PubMed Central  Google Scholar  * Tsai, K. Y., MacPherson, D., Rubionson,


D. A., Crowley, D., and Jacks, T. ARF is not required for apoptosis in Rb mutant mouse embryos. _Curr. Biol._ (in the press). * Irwin, M. et al. Role for the p53 homologue p73 in


E2F-1-induced apoptosis. _Nature_ 407, 645–648 (2000). Article  CAS  PubMed  Google Scholar  * Lissy, N. A., Davis, P. K., Irwin, M., Kaelin, W. G. & Dowdy, S. F. A common E2F-1 and p73


pathway mediates cell death induced by TCR activation. _Nature_ 407, 642–645 (2000). Article  CAS  PubMed  Google Scholar  * Stiewe, T. & Putzer, B. M. Role of the p53-homologue p73 in


E2F1-induced apoptosis. _Nature Genet._ 26, 464–469 (2000). Article  CAS  PubMed  Google Scholar  * Ishida, S. et al. Role for E2F in control of both DNA replication and mitotic functions as


revealed from DNA microarray analysis. _Mol. Cell. Biol._ 21, 4684–4699 (2001). Article  CAS  PubMed  PubMed Central  Google Scholar  * Muller, H. et al. E2Fs regulate the expression of


genes involved in differentiation, development, proliferation, and apoptosis. _Genes Dev._ 15, 267–285 (2001). Article  CAS  PubMed  PubMed Central  Google Scholar  * Kowalik, T. F.,


DeGregori, J., Leone, G., Jakoi, L. & Nevins, J. R. E2F1-specific induction of apoptosis and p53 accumulation, which is blocked by Mdm2. _Cell Growth Differ._ 9, 113–118. (1998). CAS 


PubMed  Google Scholar  * Leone, G. et al. Myc requires distinct E2F activities to induce S phase and apoptosis. _Mol. Cell_ 8, 105–113 (2001). Article  CAS  PubMed  Google Scholar  * Vigo,


E. et al. CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase. _Mol. Cell. Biol._ 19, 6379–6395 (1999). Article  CAS  PubMed  PubMed Central  Google


Scholar  * Tsai, K. Y. et al. Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos. _Mol. Cell_ 2, 293–304 (1998).BY


INTERCROSSING THE _RB_ AND _E2F1_ MUTANT MOUSE STRAINS, THE AUTHORS SHOW THAT E2F1 LOSS CAUSES A SIGNIFICANT REDUCTION IN THE LEVELS OF ECTOPIC S-PHASE ENTRY, P53-DEPENDENT- AND


P53-INDEPENDENT-APOPTOSIS THAT ARISES IN PRB-DEFICIENT EMBRYOS. THIS AMELIORATES THE DEFECTIVE ERYTHROPOIESIS AND THEREBY EXTENDS THE LIFESPAN OF THE EMBRYO BY SEVERAL DAYS. Article  CAS 


PubMed  Google Scholar  * Ziebold, U., Reza, T., Caron, A. & Lees, J. A. E2F3 contributes both to the inappropriate proliferation and to the apoptosis arising in Rb mutant embryos.


_Genes Dev._ 15, 386–391 (2001).THIS STUDY SHOWS THAT E2F3 LOSS ALMOST COMPLETELY SUPPRESSES THE INAPPROPRIATE PROLIFERATION, P53-DEPENDENT- AND P53-INDEPENDENT-APOPTOSIS IN PRB-DEFICIENT


EMBRYOS. AS THE DEGREE OF SUPPRESSION EXCEEDS THAT WHICH RESULTS FROM THE LOSS OF E2F1, THIS INDICATES E2F3 CAN INDUCE APOPTOSIS _IN VIVO_ INDEPENDENTLY OF E2F1. Article  CAS  PubMed  PubMed


Central  Google Scholar  * Pan, H. et al. Key roles for E2F1 in signaling p53-dependent apoptosis and in cell division within developing tumors. _Mol. Cell_ 2, 283–292 (1998). Article  CAS


  PubMed  Google Scholar  * Yamasaki, L. et al. Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/−) mice. _Nature Genet._ 18, 360–364 (1998). Article  CAS  PubMed 


Google Scholar  * Field, S. J. et al. E2F-1 functions in mice to promote apoptosis and suppress proliferation. _Cell_ 85, 549–561 (1996). Article  CAS  PubMed  Google Scholar  * Yamasaki, L.


et al. Tumor induction and tissue atrophy in mice lacking E2F-1. _Cell_ 85, 537–548 (1996).THIS STUDY EXAMINES THE PHENOTYPIC CONSEQUENCES OF E2F1 DEFICIENCY. IN ADDITION TO VARIOUS


DEVELOPMENTAL DEFECTS, THE _E2F1_ MUTANT MICE WERE UNEXPECTEDLY FOUND TO HAVE AN INCREASED SUSCEPTIBILITY TO TUMOURS. Article  CAS  PubMed  Google Scholar  * Zhu, J. W., DeRyckere, D., Li,


F. X., Wan, Y. Y. & DeGregori, J. A role for E2F1 in the induction of ARF, p53, and apoptosis during thymic negative selection. _Cell Growth Differ._ 10, 829–838 (1999). CAS  PubMed 


Google Scholar  * Garcia, I., Murga, M., Vicario, A., Field, S. J. & Zubiaga, A. M. A role for E2F1 in the induction of apoptosis during thymic negative selection. _Cell Growth Differ._


11, 91–98 (2000). CAS  PubMed  Google Scholar  * Humbert, P. O. et al. E2F4 is essential for normal erythrocyte maturation and neonatal viability. _Mol. Cell_ 6, 281–291 (2000). Article  CAS


  PubMed  Google Scholar  * Meng, R. D., Phillips, P. & El-Deiry, W. S. p53-independent increase in E2F-1 expression enhances the cytotoxic effects of etoposide and of adriamycin. _Int.


J. Oncol._ 14, 5–14 (1999). CAS  PubMed  Google Scholar  * Lin, W. C., Lin, F. T. & Nevins, J. R. Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent


phosphorylation. _Genes Dev._ 15, 1833–1844 (2001). CAS  PubMed  PubMed Central  Google Scholar  * Maser, R. S. et al. Mre11 complex and DNA replication: linkage to E2F and sites of DNA


synthesis. _Mol. Cell. Biol._ 21, 6006–6016 (2001). Article  CAS  PubMed  PubMed Central  Google Scholar  * Zhu, J. W. et al. E2F1 and E2F2 determine thresholds for antigen-induced T-cell


proliferation and suppress tumorigenesis. _Mol. Cell. Biol._ 21, 8547–8564 (2001). Article  CAS  PubMed  PubMed Central  Google Scholar  * Dyson, N. et al. Analysis of p107-associated


proteins: p107 associates with a form of E2F that differs from pRB-associated E2F-1. _J. Virol._ 67, 7641–7647 (1993). CAS  PubMed  PubMed Central  Google Scholar  * Beijersbergen, R. L. et


al. E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 _in vivo_. _Genes Dev._ 8, 2680–2690 (1994). Article  CAS  PubMed  Google Scholar  * Hijmans,


E. M., Voorhoeve, P. M., Beijersbergen, R. L., van't Veer, L. J. & Bernards, R. E2F-5, a new E2F family member that interacts with p130 _in vivo_. _Mol. Cell. Biol._ 15, 3082–3089


(1995). Article  CAS  PubMed  PubMed Central  Google Scholar  * Vairo, G., Livingston, D. M. & Ginsberg, D. Functional interaction between E2F-4 and p130: evidence for distinct


mechanisms underlying growth suppression by different retinoblastoma protein family members. _Genes Dev._ 9, 869–881 (1995). Article  CAS  PubMed  Google Scholar  * Ikeda, M. A., Jakoi, L.


& Nevins, J. R. A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation. _Proc. Natl Acad. Sci. USA_ 93, 3215–3220 (1996). Article  CAS 


PubMed  PubMed Central  Google Scholar  * Moberg, K., Starz, M. A. & Lees, J. A. E2F-4 switches from p130 to p107 and pRB in response to cell-cycle re-entry. _Mol. Cell. Biol._ 16,


1436–1449 (1996). Article  CAS  PubMed  PubMed Central  Google Scholar  * Muller, H. et al. Induction of S-phase entry by E2F transcription factors depends on their nuclear localization.


_Mol. Cell. Biol._ 17, 5508–5520 (1997).THE AUTHORS SHOW THAT THE ABILITY OF THE ACTIVATING E2FS TO INDUCE QUIESCENT CELLS TO RE-ENTER THE CELL CYCLE IS DEPENDENT ON THEIR NUCLEAR


LOCALIZATION. THIS IS DETERMINED BY A CANONICAL BASIC NLS WITHIN THE AMINO-TERMINAL DOMAIN. BY CONTRAST, E2F4 IS UNABLE TO INDUCE CELL CYCLE RE-ENTRY AS A RESULT OF ITS CYTOPLASMIC


LOCALIZATION. Article  CAS  PubMed  PubMed Central  Google Scholar  * Verona, R. et al. E2F activity is regulated by cell cycle-dependent changes in subcellular localization. _Mol. Cell.


Biol._ 17, 7268–7282 (1997).THIS STUDY SHOWS THAT ECTOPICALLY EXPRESSED ACTIVATING E2FS ARE NUCLEAR, WHEREAS E2F4 IS PREDOMINANTLY CYTOPLASMIC, AND THE DIFFERENTIAL LOCALIZATION OF THESE


PROTEINS ACCOUNTS FOR THE PRONOUNCED DIFFERENCES IN THEIR ABILITY TO ACTIVATE TRANSCRIPTION. IT CONFIRMS THAT THE ENDOGENOUS E2F4–DP COMPLEXES ARE ALSO SEQUESTERED IN THE CYTOPLASM AND SHOWS


THAT THESE SPECIES BECOME PREDOMINANTLY NUCLEAR WHEN THEY ARE BOUND TO PRB OR P130 IN G0/G1. THIS INDICATES THAT E2F4 IS PRIMARILY INVOLVED IN THE REPRESSION RATHER THAN THE ACTIVATION OF


E2F-RESPONSIVE GENES. Article  CAS  PubMed  PubMed Central  Google Scholar  * Magae, J., Wu, C. L., Illenye, S., Harlow, E. & Heintz, N. H. Nuclear localization of DP and E2F


transcription factors by heterodimeric partners and retinoblastoma protein family members. _J. Cell Sci._ 109, 1717–1726 (1996). CAS  PubMed  Google Scholar  * Gaubatz, S., Lees, J. A.,


Lindeman, G. J. & Livingston, D. M. E2F4 is exported from the nucleus in a CRM1-dependent manner. _Mol. Cell. Biol._ 21, 1384–1392 (2001). Article  CAS  PubMed  PubMed Central  Google


Scholar  * Iavarone, A. & Massague, J. E2F and histone deacetylase mediate transforming growth factor-β repression of cdc25A during keratinocyte cell cycle arrest. _Mol. Cell. Biol._ 19,


916–922 (1999). Article  CAS  PubMed  PubMed Central  Google Scholar  * Dalton, S. Cell cycle regulation of the human _CDC2_ gene. _EMBO J._ 11, 1797–1804 (1992). Article  CAS  PubMed 


PubMed Central  Google Scholar  * Lam, E. W. & Watson, R. J. An E2F-binding site mediates cell-cycle regulated repression of mouse _B-myb_ transcription. _EMBO J._ 12, 2705–2713 (1993).


Article  CAS  PubMed  PubMed Central  Google Scholar  * Hsiao, K. M., McMahon, S. L. & Farnham, P. J. Multiple DNA elements are required for the growth regulation of the mouse _E2F1_


promoter. _Genes Dev._ 8, 1526–1537 (1994). Article  CAS  PubMed  Google Scholar  * Tommasi, S. & Pfeifer, G. P. _In vivo_ structure of the human _cdc2_ promoter: release of a p130–E2F-4


complex from sequences immediately upstream of the transcription initiation site coincides with induction of _cdc2_ expression. _Mol. Cell. Biol._ 15, 6901–6913 (1995). Article  CAS  PubMed


  PubMed Central  Google Scholar  * Huet, X., Rech, J., Plet, A., Vie, A. & Blanchard, J. M. Cyclin A expression is under negative transcriptional control during the cell cycle. _Mol.


Cell. Biol._ 16, 3789–3798 (1996). Article  CAS  PubMed  PubMed Central  Google Scholar  * Zwicker, J., Liu, N., Engeland, K., Lucibello, F. C. & Muller, R. Cell cycle regulation of E2F


site occupation _in vivo_. _Science_ 271, 1595–1597 (1996). Article  CAS  PubMed  Google Scholar  * Bruce, J. L., Hurford, R. K. Jr, Classon, M., Koh, J. & Dyson, N. Requirements for


cell cycle arrest by p16INK4a. _Mol. Cell_ 6, 737–742 (2000). Article  CAS  PubMed  Google Scholar  * Gaubatz, S. et al. E2F4 and E2F5 play an essential role in pocket protein-mediated G1


control. _Mol. Cell_ 6, 729–735 (2000).THIS STUDY SHOWS THAT _E2F4–E2F5_ DOUBLE MUTANT MEFS ARE UNABLE TO ARREST IN RESPONSE TO THE OVER-EXPRESSION OF THE CDK INHIBITOR P16, PROVIDING DIRECT


GENETIC EVIDENCE FOR THE ROLE OF THE REPRESSIVE E2FS IN MEDIATING CELL-CYCLE EXIT. Article  CAS  PubMed  Google Scholar  * Hurford, R. K. Jr, Cobrinik, D., Lee, M. H. & Dyson, N. pRB


and p107/p130 are required for the regulated expression of different sets of E2F responsive genes. _Genes Dev._ 11, 1447–1463 (1997).THE COMBINED LOSS OF P107 AND P130 IS SHOWN TO CAUSE A


SIGNIFICANT UPREGULATION IN THE EXPRESSION OF KNOWN E2F-RESPONSIVE GENES IN G0/G1 CELLS, AND SUPPORTS THE ROLE OF THESE POCKET PROTEINS IN THE REPRESSION OF THESE TARGET GENES. Article  CAS


  PubMed  Google Scholar  * Lindeman, G. J. et al. A specific, nonproliferative role for E2F-5 in choroid plexus function revealed by gene targeting. _Genes Dev._ 12, 1092–1098 (1998).


Article  CAS  PubMed  PubMed Central  Google Scholar  * Rempel, R. E. et al. Loss of E2F4 activity leads to abnormal development of multiple cellular lineages. _Mol. Cell_ 6, 293–306 (2000).


Article  CAS  PubMed  Google Scholar  * Persengiev, S. P., Kondova, I. I. & Kilpatrick, D. L. E2F4 actively promotes the initiation and maintenance of nerve growth factor-induced cell


differentiation. _Mol. Cell. Biol._ 19, 6048–6056 (1999). Article  CAS  PubMed  PubMed Central  Google Scholar  * Cobrinik, D. et al. Shared role of the pRB-related p130 and p107 proteins in


limb development. _Genes Dev._ 10, 1633–1644 (1996). Article  CAS  PubMed  Google Scholar  * Dahiya, A., Wong, S., Gonzalo, S., Gavin, M. & Dean, D. C. Linking the Rb and polycomb


pathways. _Mol. Cell_ 8, 557–569 (2001).THIS PAPER IS ONE OF AN IMPORTANT SERIES FROM THE DEAN LAB THAT EXAMINES THE ABILITY OF PRB TO ASSOCIATE WITH HISTONE-MODIFYING ENZYMES AND REPRESS


E2F-RESPONSIVE GENES. ITS PRIMARY FOCUS IS TO SHOW THAT AN E2F–PRB–CTBP–HPC2 COMPLEX CAN REPRESS THE _CYCLIN A_ GENE. HOWEVER, IT ALSO PROVIDES KEY INFORMATION ABOUT _IN VIVO_ TIMING OF THE


PRB-MEDIATED TRANSCRIPTIONAL REPRESSION. USING CHIP ASSAYS, THE AUTHORS CONFIRM THE FINDING THAT PRB DOES NOT ASSOCIATE WITH E2F-RESPONSIVE PROMOTERS IN CELLS THAT RETAIN THE ABILITY TO


DIVIDE. THEY FURTHER SHOW THAT PRB BECOMES PROMOTER BOUND IN CELLS THAT HAVE TO BE INDUCED TO EXIT THE CELL CYCLE PERMANENTLY THROUGH THE SUSTAINED EXPRESSION OF P16. Article  CAS  PubMed 


Google Scholar  * Altiok, S., Xu, M. & Spiegelman, B. M. PPAR-γ induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A. _Genes Dev._ 11,


1987–1998 (1997). Article  CAS  PubMed  PubMed Central  Google Scholar  * Slomiany, B. A., D'Arigo, K. L., Kelly, M. M. & Kurtz, D. T. C/EBPα inhibits cell growth via direct


repression of E2F-DP-mediated transcription. _Mol. Cell. Biol._ 20, 5986–5997 (2000). Article  CAS  PubMed  PubMed Central  Google Scholar  * Porse, B. T. et al. E2F repression by C/EBPα is


required for adipogenesis and granulopoiesis _in vivo_. _Cell_ 107, 247–258 (2001). Article  CAS  PubMed  Google Scholar  * Chen, P. L., Riley, D. J., Chen, Y. & Lee, W. H.


Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs. _Genes Dev._ 10, 2794–2804 (1996). Article  CAS  PubMed  Google Scholar


  * Chen, P. L., Riley, D. J., Chen-Kiang, S. & Lee, W. H. Retinoblastoma protein directly interacts with and activates the transcription factor NF-IL6. _Proc. Natl Acad. Sci. USA_ 93,


465–469 (1996). Article  CAS  PubMed  PubMed Central  Google Scholar  * Thomas, D. M. et al. The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic


differentiation. _Mol. Cell_ 8, 303–316 (2001). Article  CAS  PubMed  Google Scholar  * Morkel, M., Wenkel, J., Bannister, A. J., Kouzarides, T. & Hagemeier, C. An E2F-like repressor of


transcription. _Nature_ 390, 567–568 (1997). Article  CAS  PubMed  Google Scholar  * Cartwright, P., Muller, H., Wagener, C., Holm, K. & Helin, K. E2F-6: a novel member of the E2F family


is an inhibitor of E2F-dependent transcription. _Oncogene_ 17, 611–623 (1998). Article  CAS  PubMed  Google Scholar  * Gaubatz, S., Wood, J. G. & Livingston, D. M. Unusual proliferation


arrest and transcriptional control properties of a newly discovered E2F family member, E2F-6. _Proc. Natl Acad. Sci. USA_ 95, 9190–9195 (1998). Article  CAS  PubMed  PubMed Central  Google


Scholar  * Trimarchi, J. M., Fairchild, B., Wen, J. & Lees, J. A. The E2F6 transcription factor is a component of the mammalian Bmi1-containing polycomb complex. _Proc. Natl Acad. Sci.


USA_ 98, 1519–1524 (2001). Article  CAS  PubMed  PubMed Central  Google Scholar  * van Lohuizen, M. Functional analysis of mouse Polycomb group genes. _Cell Mol. Life Sci._ 54, 71–79 (1998).


Article  CAS  PubMed  Google Scholar  * Jacobs, J. J. & van Lohuizen, M. Cellular memory of transcriptional states by Polycomb-group proteins. _Semin. Cell Dev. Biol._ 10, 227–235


(1999). Article  CAS  PubMed  Google Scholar  * Francis, N. J. & Kingston, R. E. Mechanisms of transcriptional memory. _Nature Rev. Mol. Cell Biol._ 2, 409–421 (2001). Article  CAS 


Google Scholar  * Haupt, Y., Alexander, W. S., Barri, G., Klinken, S. P. & Adams, J. M. Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis


in μ-myc transgenic mice. _Cell_ 65, 753–763 (1991). Article  CAS  PubMed  Google Scholar  * van Lohuizen, M. et al. Identification of cooperating oncogenes in μ-myc transgenic mice by


provirus tagging. _Cell_ 65, 737–752 (1991). Article  CAS  PubMed  Google Scholar  * Jacobs, J. J. et al. Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis


via INK4a/ARF. _Genes Dev._ 13, 2678–2690 (1999). Article  CAS  PubMed  PubMed Central  Google Scholar  * Dynlacht, B. D., Brook, A., Dembski, M., Yenush, L. & Dyson, N. DNA-binding and


_trans_-activation properties of Drosophila E2F and DP proteins. _Proc. Natl Acad. Sci. USA_ 91, 6359–6363 (1994). Article  CAS  PubMed  PubMed Central  Google Scholar  * Frolov, M. V. et


al. Functional antagonism between E2F family members. _Genes Dev._ 15, 2146–2160 (2001)._DROSOPHILA_ HAS TWO E2FS, DE2F1 AND DE2F2. THIS PAPER SHOWS THAT DE2F2 IS A REPRESSOR OF


E2F-RESPONSIVE GENES AND ITS MUTATION ALMOST COMPLETELY SUPPRESSES THE PHENOTYPIC DEFECTS THAT RESULT FROM DE2F1-LOSS. SO, DE2F1 AND DE2F2 ANTOGONIZE EACH OTHERS FUNCTION _IN VIVO_. Article


  CAS  PubMed  PubMed Central  Google Scholar  * Dyson, N. & Harlow, E. Adenovirus E1A targets key regulators of cell proliferation. _Cancer Surv._ 12, 161–195 (1992). CAS  PubMed 


Google Scholar  * Lee, M. H. et al. Targeted disruption of p107: functional overlap between p107 and Rb. _Genes Dev._ 10, 1621–1632 (1996). Article  CAS  PubMed  Google Scholar  * Aalfs, J.


D. & Kingston, R. E. What does 'chromatin remodeling' mean? _Trends Biochem Sci._ 25, 548–555 (2000). Article  CAS  PubMed  Google Scholar  * Jenuwein, T. & Allis, C. D.


Translating the histone code. _Science_ 293, 1074–1080 (2001). Article  CAS  PubMed  Google Scholar  Download references AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Center for Cancer


Research, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, 02139, Massachusetts, USA Jeffrey M. Trimarchi & Jacqueline A. Lees Authors * Jeffrey M. Trimarchi


View author publications You can also search for this author inPubMed Google Scholar * Jacqueline A. Lees View author publications You can also search for this author inPubMed Google Scholar


CORRESPONDING AUTHOR Correspondence to Jacqueline A. Lees. RELATED LINKS RELATED LINKS DATABASES ENCYCLOPEDIA OF LIFE SCIENCES: cell division cycle nucleosome structures  LOCUSLINK: ATR


_B-myb_ _cdc2_ CRM1 _cyclin A2_ cyclin E dE2F2 DP1 _E2f1_ _E2f2_ _E2f3_ _E2f4_ _E2f5_ p16 p19ARF p21 p27 p107 p130 pRB RYBP SUV39H2 thymidylate synthetase  SWISS-PROT: ATM Bmi-1 CBFA1 Cdc2


Cdc6 Cdc25A Cdk2 Cdk4 Cdk6 c-myc cyclin A cyclin D1 dE2F1 dihydrofolate reductase E2F1 E2F2 E2F3 E2F4 E2F5 E2F6 HP1 Mre11 ORC1 p53 p73 PPAR-γ SUV39H1 thymidine kinase GLOSSARY * CHECKPOINT


PATHWAYS The classic definition of a checkpoint pathway/protein is one that is not required for normal cell-cycle regulation but is essential for the ability of the cell to arrest in


response to a stress condition. Frequently, this term is used less strictly to describe proteins that have a key role in cell-cycle-stress responses, regardless of their role in normal


cell-cycle regulation. * p53 The p53 transcription factor is activated in response to various stress conditions, including DNA damage. It activates various target genes that trigger either


apoptosis or cell-cycle arrest, depending on the cell type and the stress conditions. p53 is a tumour suppressor and it, or its upstream regulators, are disrupted in a large proportion of


human tumours. * CHROMATIN-IMMUNOPRECIPITATION (ChIP) ASSAYS ChIP assays can be used to monitor the association of DNA-binding proteins with specific promoters _in vivo_. Briefly, live cells


are treated with crosslinking agents to tether the proteins to the DNA. The selected protein is then recovered by immunoprecipitation, the crosslinking is reversed and the co-precipitating


DNA is screened for the enrichment of specific promoter fragments using the polymerase chain reaction (PCR). * TRANSFORMATION Transformation is the process by which a primary cell becomes a


tumour cell. It is generally characterized by a reduction in growth-factor dependence, a failure to arrest growth in response to contact inhibition, and the ability to grow in soft agar


(that is, without attachment). * PRIMARY CELLS Primary cells are cells that are derived from a living organism. They undergo a limited, predetermined number of cell divisions before


arresting permanently in G0 — a process that is called cellular senescence. * p19ARF The _p19__ARF_ gene (the human equivalent is called _p14__ARF_) is expressed from the _Ink4_ locus and


its coding sequence partially overlaps with that of _p16__INK4a_. The p19ARF protein activates p53 by binding to Mdm2 (an E3 ubiquitin ligase) and prevents it from triggering p53


degradation. * THE NBS1/MRE11 COMPLEX The _Nbs1_ gene was identified by virtue of its mutation in the inherited chromosome instability disorder Nijmegen breakage syndrome (NBS). Its protein


product, Nibrin, forms a complex with the DNA-repair proteins Mre11 and Rad50. This complex seems to have an important role in recombinational DNA repair, replication and the activation of a


DNA-damage induced S-phase checkpoint. * POLYCOMB COMPLEX _Polycomb (Pc)_ was identified as a dominant mutation in _Drosophila_ that led to the presence of sex combs on the second and third


legs of male flies instead of only the first leg. The _Drosophila_ polycomb group (PcG) includes several genes that yield similar homeotic transformation phenotypes when mutated. Their


protein products associate with one another to form at least two possible Polycomb complexes. These maintain the repression of _hox_ gene expression, which is essential for embryonic


patterning. The PcG also exists in mammals, but seems much more complex. RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Trimarchi, J., Lees, J. Sibling


rivalry in the E2F family. _Nat Rev Mol Cell Biol_ 3, 11–20 (2002). https://doi.org/10.1038/nrm714 Download citation * Issue Date: 01 January 2002 * DOI: https://doi.org/10.1038/nrm714 SHARE


THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to


clipboard Provided by the Springer Nature SharedIt content-sharing initiative